This most recent study is in addition to five clinical trials which found that MedCline™ has been shown to be an effective treatment in GERD patients suffering with nocturnal reflux symptoms
Highlights from these studies include:
· 72% reduction in nocturnal GERD symptom scores
· 95% reported an overall improvement in sleep quality
· 75% reported less difficulty with sliding down at night
· 67% reduction in nocturnal regurgitation scores
The 2015 clinical trials are added to a growing library of clinical data, including the randomized controlled trial conducted by the Medical University of South Carolina published in the June issue of the Journal of Clinical Gastroenterology, which showed:
· 87% reduction in esophageal acid exposure compared to bed wedges
· 38% reduction in reflux episodes than bed wedges
· Nearly 2x more comfortable than bed wedges
ABOUT AMENITY HEALTH
Amenity Health was founded in 2011 by retired physician Carl Melcher, M.D. In addition to his medical expertise, Dr. Melcher is also an entrepreneur with success in the technology and medical industries. Dr. Melcher has been a life-long sufferer from chronic acid reflux or GERD (Gastroesphageal Reflux Disease). In recent years, he was diagnosed with the esophageal cancer precursor, Barrett’s Esophagus. With the desire to resolve his own condition, as well as help the millions of others who also suffer, he hypothesized that, if done properly, positional therapy could be an effective treatment option for the disease. Partnering with talented engineers and designers, Dr. Melcher and the design team began developing what is now known today as MedCline and put positional therapy for GERD back on the map.
After several years of thorough and rigorous development, MedCline was clinically verified by former AGA president, Donald O Castell, M.D. using an impedance/PH study performed at the Medical University of South Carolina. Dr. Castell and his team found MedCline to be far superior at reducing acid exposure than a traditional bed wedge. Later that year, Scott Gabbard, M.D. of Cleveland Clinic approached Amenity Health interested in testing the MedCline reflux relief system using validated quality of life questionnaires, designed to specifically tabulate nocturnal GERD symptoms. The results from these studies were overwhelmingly positive, showing better score improvements than a leading proton-pump inhibitor (PPI) drug for which the questionnaires were originally drafted. To date, MedCline has been evaluated in 6 clinical trials with for varying sub-populations of GERD patients suffering with nocturnal symptoms.
Amenity Health aims to make MedCline available to all GERD sufferers, particularly those looking for alternative or supplemental options. Our mission is to provide much needed relief for those suffering from nocturnal acid reflux and heartburn to get quality, restorative sleep leading to a higher health-related quality of life. www.amenityhealth.com